On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a "listening session" focusing on USPTO-FDA collaboration initiatives proposed.
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a “listening session” focusing on USPTO-FDA collaboration initiatives.
The law is in a state of disarray that has led to inconsistent case decisions, deep uncertainty in the innovative, investment and legal communities, and unpredictable outcomes in prosecution and litigation. David Kappos, Paul Michel, Corey Salsberg and Matthew Dowd argue that the United States legislators must act to ensure the country maintains its long-standing competitive edge in the global innovation race